National Comprehensive Cancer Network



About NCCN

Breast Cancer Panel - Disclosures as of 4/24/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Benjamin O. Anderson, MD

General Electric;
sanofi-aventis U.S.

None

None

None

5/31/2013

Sarah L. Blair, MD

None

None

None

None

7/22/2013

Harold J. Burstein, MD, PhD

None

None

None

None

5/23/2013

Amy Cyr, MD

None

None

None

None

5/22/2013

Anthony D. Elias, MD

Exelixis Inc.;
Genentech, Inc.;
Astellas;
Medivation;
NeuVax

Genentech, Inc.

None

None

6/7/2013

William B. Farrar, MD

None

None

None

None

8/19/2013

Fayna Ferkle, PharmD

None

None

None

None

3/26/2014

Andres Forero, MD

Abbott Laboratories;
Biogen Idec;
Celgene Corporation;
Daiichi- Sankyo Co.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

5/5/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Sharon Hermes Giordano, MD, MPH

None

None

None

None

5/24/2013

Lori J. Goldstein, MD

Novartis Pharmaceuticals Corporation;
Dompe

Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Nanostring;
Syntax

None

Novartis Pharmaceuticals Corporation

11/11/2013

William J. Gradishar, MD

None

Bayer HealthCare;
Eisai Inc.;
Genentech, Inc.;
Genomic Health, Inc.;
Myriad Genetic Laboratories, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

1/21/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Daniel F. Hayes, MD

Janssen Pharmaceuticals

Inbiomotion;
Oncimmune

None

None

11/20/2013

Clifford A. Hudis, MD

Alliance;
I-SPY2

None

None

ASCO;
Breast Cancer Research Foundation

8/16/2013

Steven Jay Isakoff, MD, PhD

Abbott Laboratories

Myriad Genetic Laboratories, Inc.

None

None

3/7/2013

Rashmi Kumar, PhD

None

None

None

None

5/28/2013

P. Kelly Marcom, MD

Abbott Laboratories;
Veridex, LLC

Novartis Pharmaceuticals Corporation;
Nanostring

None

None

7/22/2013

Ingrid A. Mayer, MD

None

None

None

None

10/1/2012

Joan S. McClure, MS

None

None

None

None

8/13/2013

Beryl McCormick, MD

None

None

None

None

8/19/2013

Robert S. Miller, MD

None

None

None

None

1/15/2014

Mark Pegram, MD

       

Pending

Lori J. Pierce, MD

None

Genomic Health, Inc.

UpToDate

None

8/16/2013

Elizabeth C. Reed, MD

Agendia BV;
Novartis Pharmaceuticals Corporation

UnitedHealthcare

None

None

8/20/2013

Kilian E. Salerno, MD

None

None

None

None

10/10/2013

Lee S. Schwartzberg, MD, FACP

Bristol-Myers Squibb Company;
Eisai Inc.

Amgen Inc.;
Eisai Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

8/26/2013

Dorothy Shead, MS

None

None

None

None

8/19/2013

Mary Lou Smith, JD, MBA

Genentech, Inc.

None

None

Gateway for Cancer Research Foundation;
National Accreditation Program for Breast Centers

7/20/2013

Hatem Soliman, MD

Agendia BV

Agendia BV;
Celgene Corporation;
NanoString;
Veridex, LLC

None

None

12/5/2012

George Somlo, MD

Celgene Corporation;
Genentech, Inc.;
National Cancer Institute;
Veridex, LLC

Celgene Corporation;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Abraxane;
Roche Laboratories, Inc.

None

None

7/12/2013

John H. Ward, MD

None

None

None

None

1/17/2013

Richard Zellars, MD

None

None

None

None

11/5/2013